Veterinary Molecular Diagnostics Market to Reach USD 2.65 Billion by 2032 at 8.69% CAGR

Key Highlights

• The Veterinary Molecular Diagnostics Market was valued at USD 1.48 billion in 2025 and is expected to reach USD 2.65 billion by 2032, expanding at an 8.69% CAGR during 2026–2032. That growth places faster and more precise animal-disease testing higher on laboratory investment agendas.
• Kits and reagents are expected to dominate the product segment because they represent the majority of commercial offerings and are widely based on PCR technology.
• North America is expected to dominate during the forecast period, supported by U.S. pet adoption, major diagnostics companies and animal-welfare initiatives.
• Rising zoonotic disease prevalence remains the primary growth driver, increasing the value of early pathogen detection in livestock and companion animals.
• Portable testing, next-generation sequencing, automated sample preparation and AI-assisted PCR interpretation are widening the competitive field.

Why This Matters Now

The Veterinary Molecular Diagnostics Market is moving from a specialist laboratory category into a frontline animal-health and public-health capability. Rising zoonotic disease risk, faster molecular testing and growing veterinary expenditure are forcing providers, diagnostic companies and regulators to shorten the interval between infection, detection and intervention.

MMR cites CDC data showing that 6 in 10 known infectious diseases in humans can spread from animals, while 3 in 4 new or emerging infectious diseases can be carried by animals. That makes veterinary diagnostics relevant not only to animal care but also to surveillance and outbreak preparedness.

Market Overview

The Veterinary Molecular Diagnostics Market was valued at USD 1.48 billion in 2025 and is forecast to reach USD 2.65 billion by 2032 at an 8.69% CAGR. Molecular diagnostics examine animal pathogens using techniques that can deliver shorter testing times, clearer differentiation between virulent and avirulent strains, and high specificity and sensitivity compared with traditional methods.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/103554/

Demand is expanding beyond emergency disease testing. Higher pet adoption, animal-health spending, demand for animal-derived food and growing interest in pet insurance are increasing the economic value of routine and preventive veterinary diagnostics.

Key Trends Driving Growth

The Veterinary Molecular Diagnostics Market is gaining urgency because zoonotic infections can move across animal and human populations. Earlier identification gives veterinarians and livestock operators a better chance to isolate disease, protect herds and reduce wider transmission risks.

PCR remains central to commercial adoption. MMR states that many diagnostic kits are PCR-based and used to screen related groups of diseases. Assays cited in the report include testing for Porcine Epidemic Diarrhea Virus, Porcine Deltacoronavirus and Transmissible Gastroenteritis Virus.

The Veterinary Molecular Diagnostics Market is also moving toward decentralized testing. Thermo Fisher Scientific introduced a portable molecular analyzer for on-site avian influenza testing with results in under 40 minutes, demonstrating how point-of-care systems can reduce response times during poultry outbreaks.

Digital interpretation is emerging as another layer. Indical Bioscience partnered with a biotech company to develop AI-driven software for interpreting PCR results and reducing human error in high-throughput laboratories. MMR does not provide a separate AI market value, so the technology is best viewed as a workflow enhancer rather than a standalone segment.

Segment Insights

• Dominant Segment Kits and Reagents: Kits and reagents are expected to dominate because they account for the majority of commercial products, support a broad range of veterinary applications and benefit from high specificity and effectiveness. Their recurring use makes consumables an important revenue engine within the Veterinary Molecular Diagnostics Market.
• Fastest-Growing Segment: The accessible MMR page does not identify a statistically supported fastest-growing product, technology or application segment. The report states that diagnostic kits and reagents are expected to develop rapidly, but it does not publish a segment CAGR.
• Product  Instruments: Instruments support sample processing and molecular analysis across veterinary laboratories and surveillance programs. Their value rises as testing volume and automation requirements increase.
• Product  Software and Services: Software and services complete the product structure. Their commercial relevance increases as PCR, sequencing and genomic workflows generate larger volumes of data requiring interpretation and management.
• Technology: The Veterinary Molecular Diagnostics Market is segmented into PCR, microarray and DNA sequencing. The accessible report page does not assign a dominant share or fastest CAGR to these technologies.
• Application: Infectious diseases, genetics and other applications form the application structure. Infectious-disease detection receives substantial attention in the report because of zoonotic risk and livestock pathogen surveillance.

Regional Growth Story

North America is expected to dominate the Veterinary Molecular Diagnostics Market during the forecast period. Rising pet adoption in the United States, large diagnostics companies, greater animal-welfare awareness and organized welfare initiatives support regional testing demand.

Europe is identified as the second-most lucrative region. Government support, high-quality diagnostic procedures and veterinary diagnostic centres strengthen the operating environment, with Germany and the UK included in MMR's country analysis.

Asia Pacific includes China, India, Japan and South Korea and is identified by MMR as an important future hotspot. However, high diagnostic costs, regulatory requirements and insufficient epidemiological information for some virulent diseases can restrict adoption in developing economies.

Competitive Landscape

Competition in the Veterinary Molecular Diagnostics Market is shifting from simple assay availability toward speed, genomic depth and laboratory automation. Zoetis launched an expanded PCR panel for rapid detection of multidrug-resistant livestock pathogens, aligning diagnostic innovation with antimicrobial stewardship.

IDEXX Laboratories acquired a regional diagnostic specialist to integrate next-generation sequencing into its reference laboratories. The transaction signals a move toward deeper genomic information for oncology and rare infectious diseases rather than basic pathogen confirmation alone.

Qiagen's automated sample-preparation system received regulatory clearance for large-scale veterinary surveillance. For the Veterinary Molecular Diagnostics Market, that signals growing value in standardized workflows and throughput as governments and laboratories expand biosecurity programs.

Neogen's Genomic Profiling 2.0 service uses a high-density SNP chip for companion-animal screening. That extends veterinary diagnostics toward genetics-led and more personalized animal care, creating another competitive layer beyond infectious diseases.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/103554/

Recent Developments

• 14 January 2025 Zoetis: Launched an expanded PCR panel for rapid detection of multidrug-resistant livestock pathogens, supporting more targeted disease management and antimicrobial stewardship.
• 22 February 2025  IDEXX Laboratories: Completed an acquisition designed to bring next-generation sequencing into its reference laboratories and expand genomic diagnostic capability.
• 10 May 2025 Thermo Fisher Scientific: Introduced a portable analyzer capable of on-site avian influenza molecular testing with results in under 40 minutes.
• 8 August 2025  Indical Bioscience: Entered an AI-diagnostics partnership aimed at automating PCR-result interpretation and reducing laboratory error.
• 12 January 2026  Qiagen: Received regulatory clearance for automated sample preparation designed for large-scale veterinary surveillance programs.

Strategic Implications

The Veterinary Molecular Diagnostics Market still faces significant adoption barriers. High diagnostic costs, approval requirements and gaps in disease epidemiology can slow deployment, particularly where veterinary infrastructure and budgets remain limited.

For diagnostic companies, recurring kits remain attractive, but future differentiation will increasingly depend on portable testing, automated preparation, sequencing and software-supported interpretation. The Veterinary Molecular Diagnostics Market therefore rewards companies that shorten turnaround while preserving specificity and operational simplicity.

For veterinary networks and livestock operators, the commercial question is increasingly about actionable time. Tests that identify pathogens earlier can help teams move faster from suspicion to isolation, treatment decisions or surveillance response.

Future Outlook

The Veterinary Molecular Diagnostics Market is becoming a wider animal-health infrastructure category rather than a narrow laboratory niche. Faster PCR, genomic profiling, automated workflows and point-of-care systems are connecting disease surveillance, companion-animal care and livestock management more closely.

The next competitive threshold will be diagnostic systems that combine sensitive assays with rapid processing and usable clinical information. Companies that make precision testing faster, scalable and easier to deploy will shape veterinary care; laggards will remain tied to slower, fragmented diagnostic workflows.

Browse More Trending Reports

Menopausal Hot Flashes Market 

Ablation Technology Market 

Analyst Perspective

“Veterinary molecular diagnostics are moving closer to the point where speed, specificity and actionable data must be delivered together. Companies that combine rapid PCR, genomic capability and automated laboratory workflows will be better positioned as animal-health systems place greater emphasis on early detection and surveillance,” said Komal Patil, Analyst at Maximize Market Research.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

2nd Floor, Navale IT Park Phase 3

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India

+91 9607365656

sales@maximizemarketresearch.com 

https://www.maximizemarketresearch.com